FGB -455 G>A and GP IIIa PIA1/A2 polymorphisms in a group of Romanian stroke patients
References
- 1. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, et al. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 Apr;151(4):786-96. DOI: 10.1016/j.ahj.2005.11.004
- 2. Markus HS. Stroke genetics. Hum Mol Genet. 2011 Oct 15;20(R2):R124-31. DOI: 10.1093/hmg/ddr345
- 3. Cinteza M, Pana B, Cochino M, Florescu M, Margulescu M, Florian A, et al. Prevalence and control of cardiovascular risk factors in Romania cardio-zone national study. Mædica. 2007 May; 2(4):277-88.
- 4. Della-Morte D, Guadagni F, Palmirotta R, Testa G, Caso V, Paciaroni M, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012 Apr;13(5):595-613. DOI: 10.2217/pgs.12.14
- 5. Goracy J, Goracy I, Kaczmanczyk M, Brykcz M, Widwcka-Ostreska K, Taryna O, et al. Common genetic polymorphisms and environmental risk factors in Polish patients with angiographically documented coronary artery disease. Pol.J.Environ. 2011 May;20(6):1491-99.
- 6. Sheweita SA, Baghdadi H, Allam AR. Role of genetic changes in the progression of cardiovascular diseases. Int J Biomed Sci. 2011 Dec;7(4):238-48.
- 7. Imran Imran, Rusdi Lamsudin, Ponpon Idjiradinata, Tri Hanggono Achmad, Amelani Maskoen, Samekto Wibowo, et al. Association of β-fibrinogen promoter gene polymorphism (-148C/T), hyperfibrinogenemia and ischemic stroke in young adult patients. Egypt J Med Hum Genet. 2015 Jan;16(1):11-17. DOI: 10.1016/j.ejmhg.2014.09.004
- 8. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012 Oct 4;367(14):1310-20. DOI: 10.1056/NEJMoa1107477
- 9. Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P. Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS One. 2010 Feb 9;5(2):9136. DOI: 10.1371/journal.pone.0009136
- 10. Cao YJ, Zhang X, Wang WH, Zhai WQ, Qian JF, Wang JS. Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial. Chin Med J (Engl). 2013 Nov;126(21):4060-5.
- 11. Kumar A, Sagar R, Kumar P, Sahu JK, Grover A, Srivastava AK, et al. Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design. BMC Neurol. 2013 Oct 3;13:136. DOI: 10.1186/1471-2377-13-136
- 12. Martiskainen M, Pohjasvaara T, Mikkelsson J, Mäntylä R, Kunnas T, Laippala P, et al. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke. 2003 Apr;34(4):886-91. DOI: 10.1161/01.STR.0000060029.23872.55
- 13. Wu G, Cai H, Cai H, Chen Z, Tan L, Qi H, et al. Effect of the -148C/T, 448G/A, and -854G/A Polymorphisms of the β-Fibrinogen Gene on the Risk of Ischemic Stroke in Chinese Population. J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1577-90. DOI: 10.1016/j.jstrokecerebrovasdis.2015.03.029
- 14. Pongrácz E, Andrikovics H, Csornai M, Bernát IS, Nagy Z. Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients. Clin Hemorheol Microcirc. 2006;35(1-2):75-82.
- 15. Floyd CN, Ferro A. The platelet fibrinogen receptor: from megakaryocyte to the mortuary. JRSM Cardiovasc Dis. 2012 May 31;1(2). pii: cvd.2012.012007.
- 16. Galasso G, Santulli G, Piscione F, De Rosa R, Trimarco V, Piccolo R, et al. The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord. 2010 Sep 16;10:41. DOI: 10.1186/1471-2261-10-41
- 17. Floyd CN, Ellis BH, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS One. 2014 Jul 2;9(7):e100239. DOI: 10.1371/journal.pone.0100239 DOI: 10.1371/journal.pone.0101518
- 18. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost. 2011 Nov;106(5):827-38. DOI: 10.1160/TH11-08-0592
- 19. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011May;105 Suppl 1:S13-33. DOI: 10.1160/THS10-11-0720
- 20. Promega Corporation, Instructions for Use of Product(s) A1120, A1125, A1620, Wiyard Genomic DNA Purification Kit Technical Manual, Ma, USA, revised 12/2010..
- 21. Available from:. [cited 2015.10.30].
- 22. Available from:. [cited 2015.10.30].
- 23. Undas A. Fibrin clot properties and their modulation in thrombotic disorders. Thromb Haemost. 2014 Jul 3;112(1):32-42. DOI: 10.1160/TH14-01-0032
- 24. Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Rev. 2011 Jul;25(4):155-67. DOI: 10.1016/j.blre.2011.03.002
- 25. Available from:. [cited 2015.07.15].
- 26. Available from:. [cited 2015.08.05].
- 27. Pongracz E, Scweitzer K, Furesz J, Fent J, Tordai A, Nagy Z. The effects of platelet receptor GPIIb/IIIa polymorphism (Leu Pro33) on the receptor expression and platelet aggregation in patients with ishaemic stroke. Turk J Hematol. 2007 Sep;24(4):155-163.
- 28. Guo J, Liu A, Su D. Genetics of stroke. Acta Pharm Sinic 2010 Aug; 31:1055–1064. DOI: 10.1038/aps.2010.141
- 29. Siengerink B, Rosendaal F.R, Algra A. Genetic variation in fibrinogen; its relantionship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost. 2009 Mar;7(3):385-90. DOI: 10.1111/j.1538-7836.2008.03266.x
- 30. Lee SH, Kim MK, Park MS, Choi SM, Kim JT, Kim BC, et al. Beta-fibrinogen -455 G/A polymorphism in Korean ischemic stroke patients. J Clin Neurol. 2008 Mar;4(1):17-22. DOI: 10.3988/jcn.2008.4.1.17
- 31. Golenia A, Chrzanowska-Wasko J, Jagiella J, Wunk M, Ferens A, Klimkowicz-Mrowiec A, et al. The β-fibrinogen -455G/A gene polymorphism and the risk of ischaemic stroke in a Polish population. Neurol Neurochir Pol. 2013 Mar-Apr;47(2):152-6. DOI: 10.5114/ninp.2013.34462
- 32. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large vessel disease. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2880-4. DOI: 10.1161/01.ATV.17.11.2880
- 33. Liu Y, Pan J, Wang S, Li X, Huang Y. Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Chin Med J (Engl). 2002 Feb;115(2):214-6.
- 34. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. Lancet. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997 Feb 8;349(9049):385-8. DOI: 10.1016/S0140-6736(97)80010-4
- 35. Li Q, Chen BL, Ozdemir V, Ji W, Mao YM, Wang LC, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics. 2007 Jun;8(6):577-86. DOI: 10.2217/14622416.8.6.577
- 36. Floyd CN, Mustafa A, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS One. 2014 Jul 2;9(7):e101518. DOI: 10.1371/journal.pone.0101518
- 37. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1124-31. DOI: 10.1161/01.ATV.18.7.1124
- 38. Lanni F1, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M, et al. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens. 2007 Mar;25(3):551-6. DOI: 10.1097/HJH.0b013e328013cd67
- 39. Oksala NK1, Heikkinen M, Mikkelsson J, Pohjasvaara T, Kaste M, Erkinjuntti T, et al. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival. Stroke. 2007 Jan;38(1):50-5. DOI: 10.1161/01.STR.0000251719.59141.36
DOI: https://doi.org/10.1515/rrlm-2016-0002 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Language: English
Page range: 45 - 54
Submitted on: Aug 11, 2015
Accepted on: Dec 16, 2015
Published on: Mar 19, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2016 Felicia Maria Petrişor, Andreea Cătană, Dragoş Horea Mărginean, Adrian Pavel Trifa, Radu Anghel Popp, Ioan Victor Pop, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.